Cover Image
市場調查報告書

醫藥品產業的患者中心主義

Pharma's Patient Centricity

出版商 Datamonitor Healthcare 商品編碼 363587
出版日期 內容資訊 英文 45 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品產業的患者中心主義 Pharma's Patient Centricity
出版日期: 2016年02月08日 內容資訊: 英文 45 Pages
簡介

雖然明白患者中心主義在商務中是必須的,但是醫藥品產業要如何達成現在仍不明確。患者中心主義不是功能而是想法,是研究開發和開發治療的新手法。

本報告提供醫藥品產業的患者中心主義的概要與組織和文化帶來的影響,價值鏈的案例研究等彙整資料。

摘要整理

患者中心主義的促進因素與阻礙因素

  • 患者中心主義比起流程更是想法
  • 促進因素與阻礙因素
  • 參考文獻

實際業務的患者中心主義

  • 從藥物研發到商品化
  • 參考文獻

患者中心主義意味著組織和文化的變革

  • 新的想法
  • 語言的變更
  • Top-Down(由上而下)和Bottom-Up(由下而上)領導力
  • 其他產業的教訓
  • 技術實現患者中心主義尋求新的治療範例
  • 注重成果,業務將遵循
  • 患者中心主義劇本的登場
  • 參考文獻

價值鏈的案例研究

  • UCB:重新組織患者
  • Sanofi:患者中心主義的技術創新
  • LEP 去Pharma:主導患者中心主義
  • Actelion:患者相關臨床實驗方法新的方法
  • AstraZeneca:患者參與研究
  • Novo Nordisk:患者中心主義的傳統
  • Shire:對罕見疾病也擴大患者中心主義
  • 參考文獻

附錄

目錄
Product Code: DMKC0151490

Many in the industry agree that patient centricity is a business imperative, but it is unclear precisely what it means in business or organizational terms, and less clear still how to achieve it within the pharmaceutical industry. Patient centricity is not a function, but a mindset, a new way of doing R&D and of conceiving of therapeutic solutions.

There are multiple forces driving greater patient centricity. These include payers' focus on outcomes, the need for product differentiation, new digital technologies and data sources, advances in genomics and personalized medicines, and the empowered consumer. But there are as many hurdles, not least the lack of a roadmap as to how to be patient-centric, the lack of standards around patient-centric data and processes, regulatory uncertainties, disciplinary silos, and engrained attitudes clinging to traditional metrics and approaches to drug development.

This report addresses:

  • Drivers and resistors of patient centricity *Patient centricity in practice
  • Patient centricity impact on organizations and cultures
  • Selected case studies along the value chain

TABLE OF CONTENTS

EXECUTIVE SUMMARY

  • 1. Drivers and resistors of patient centricity
  • 2. Patient centricity in practice
  • 3. Patient centricity means changing organizations and cultures
  • 4. Selected case studies along the value chain

DRIVERS AND RESISTORS OF PATIENT CENTRICITY

  • 5. Patient centricity is more mindset than process
  • 6. Drivers and resistors
  • 7. Drivers
  • 8. Resistors
  • 9. Bibliography

PATIENT CENTRICITY IN PRACTICE

  • 10. From discovery to commercialization
  • 11. Bibliography

PATIENT CENTRICITY MEANS CHANGING ORGANISATIONS AND CULTURES

  • 12. New ways of thinking
  • 13. Changing the language
  • 14. Top-down and bottom-up leadership
  • 15. Lessons from other industries
  • 16. Technology enables patient centricity and demands new treatment paradigm
  • 17. Focus on outcomes, business will follow
  • 18. Patient centricity playbooks are emerging
  • 19. Bibliography

SELECTED CASE STUDIES ALONG THE VALUE CHAIN

  • 20. UCB: re-organizing around patients
  • 21. Sanofi: diffusing patient-centric innovation
  • 22. LEO Pharma: leading the pack in patient centricity
  • 23. Actelion: new approaches to patient-relevant trial measures
  • 24. AstraZeneca: engaging patients in research
  • 25. Novo Nordisk: a patient-centric heritage
  • 26. Shire: spreading patient centricity beyond rare diseases
  • 27. Bibliography

APPENDIX

  • 28. About the author
  • 29. Scope
  • 30. Methodology
Back to Top